Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine

Akesson, B.; Paulsson, K
April 1997
Occupational & Environmental Medicine;Apr1997, Vol. 54 Issue 4, p236
Academic Journal
journal article
Objectives: To study the acute effects of exposure to the increasingly used solvent, N-methyl-2-pyrrolidone (NMP) in male volunteers. Further, to determine the NMP concentration in plasma and urine during and after the exposure.Methods: Six male volunteers were exposed for eight hours on four different days to 0, 10, 25, and 50 mg/m3 NMP. Plasma was collected and urine was sampled during and after the exposure. Changes in nasal volume were measured by acoustic rhinometry and in airway resistance by spirometry.Results: The eight-hour experimental exposure to 10, 25, and 50 mg/m3 did not induce discomfort to eyes or upper airways. Acute changes in nasal volume were not found, and no changes in the spirometric data could be registered. The elimination curves suggested a non-linear pattern and at the end of exposure showed mean (range) half lifes of NMP in plasma of about 4.0 (2.9-5.8) hours and in urine 4.5 (3.5-6.6) hours. The unmetabolised NMP found in urine samples collected during exposure and at the subsequent 44 hours corresponded to about 2% of the calculated absorbed dose. At the end of the exposure there was a close correlation between exposures and the plasma concentration and urinary excretion of NMP.Conclusions: NMP was absorbed through the respiratory tract and readily eliminated from the body, mainly by biotransformation to other compounds. Exposure to 10, 25, or 50 mg/m3 NMP did not cause nose, eye, or airway irritation. Thus, NMP is a mild irritant.


Related Articles

  • Placebo and analgesic nitrous oxide for treatment of the alcohol withdrawal state. Gillman, Mark A.; Lichtigfeld, Frederick J.; Gillman, M A; Lichtigfeld, F J // British Journal of Psychiatry;Nov91, Vol. 159, p672 

    We present evidence that analgesic (as distinct from anaesthetic) nitrous oxide is superior to placebo in the treatment of the alcohol withdrawal state. 'Carbogen' as a placebo is as effective as oxygen or medical air. However, placebo alone offers a means of treating the alcohol withdrawal...

  • A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis. Calvin Lu; Hye-Seung Lee; Pappas, George P.; Dilling, Daniel F.; Burger, Charles D.; Shifren, Adrian; Veeraraghavan, Srihari; Chapman, Jeffrey T.; Parambil, Joseph; Ruoss, Stephen J.; Young, Lisa R.; Hammes, Stephen R.; Kopras, Elizabeth J.; Roads, Tammy; Krischer, Jeffrey P.; McCormack, Francis X.; Lu, Calvin; Lee, Hye-Seung; Trial of an Aromatase Inhibitor in Lymphangioleiomyomatosis Group // Annals of the American Thoracic Society;Jun2017, Vol. 14 Issue 6, p919 

    Rationale: Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease that predominantly affects women and can worsen with pregnancy, estrogen treatment, and the menstrual cycle, suggesting an important role for estrogen in disease pathogenesis.Objectives: To...

  • Intracervical misoprostol and prostaglandin E2 for labor induction Chang, Y.-K.; Chen, W.-H.; Yu, M.-H.; Liu, H.-S. // International Journal of Gynecology & Obstetrics;Jan2003, Vol. 80 Issue 1, p23 

    Objectives: To compare the safety and efficacy of misoprostol with PGE2 for induction of labor by intracervical administration. Methods: Eighty-six women with indications for labor induction at term were randomly assigned to two groups. Each woman received either 50 μg of misoprostol or 0.5...

  • Use of misoprostol on an outpatient basis for postdate pregnancy Kipikasa, J.H.; Adair, C.D.; Williamson, J.; Breen, J.M.; Medford, L.K.; Sanchez-Ramos, L. // International Journal of Gynecology & Obstetrics;Feb2005, Vol. 88 Issue 2, p108 

    Objective: Within the obstetric community, several studies suggest that cervical ripening and labor induction after 40 weeks' gestation leads to improved maternal and neonatal outcomes. The most effective drug regimen to safely promote labor has not been determined.Method:...

  • Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Groopman, Jerome E.; Gottlieb, Michael S.; Goodman, Jesse; Mitsuyasu, Ronald T.; Conant, Marcus A.; Prince, Harry; Fahey, John L.; Derezin, Marvin; Weinstein, Wilfred M.; Casavante, Conrad; Rothman, John; Rudnick, Seth A.; Volberding, Paul A.; Groopman, J E; Gottlieb, M S; Goodman, J; Mitsuyasu, R T; Conant, M A; Prince, H; Fahey, J L // Annals of Internal Medicine;May84, Vol. 100 Issue 5, p671 

    In a randomized prospective study we tested the toxicity and efficacy of recombinant alpha-2 interferon in the treatment of Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. High doses (50 X 10(6) U/m2 body surface area, intravenously) or low doses (1 X 10(6) U/m2,...

  • Impact of Mandibular Advancement Therapy on Endothelial Function in Severe Obstructive Sleep Apnea. Gagnadoux, Frédéric; Pépin, Jean-Louis; Vielle, Bruno; Bironneau, Vanessa; Chouet-Girard, Frédérique; Launois, Sandrine; Meslier, Nicole; Meurice, Jean-Claude; Xuan-Lan Nguyen; Paris, Audrey; Priou, Pascaline; Tamisier, Renaud; Trzepizur, Wojciech; Goupil, François; Fleury, Bernard; Nguyen, Xuan-Lan // American Journal of Respiratory & Critical Care Medicine;5/1/2017, Vol. 195 Issue 9, p1244 

    Rationale: Endothelial dysfunction, a major predictor of late cardiovascular events, is linked to the severity of obstructive sleep apnea (OSA).Objectives: To determine whether treatment with mandibular advancement device, the main alternative to continuous positive...

  • Poor sensitivity and consistency of microscopy in the diagnosis of low grade non-gonococcal urethritis. Smith, R.; Copas, A. J.; Prince, M.; George, B.; Walker, A. S.; Sadiq, S. T. // Sexually Transmitted Infections;Dec2003, Vol. 79 Issue 6, p487 

    Objectives: To determine the reliability of the diagnosis of non-gonococcal urethritis (NGU), and the variation between and within microscopists, from urethral smears at a large London genitourinary medicine clinic.Methods: A senior microscopist (SM) preselected 60 Gram...

  • Effects of morning phototherapy on circadian markers in seasonal affective disorder. Thompson, C.; Childs, P. A.; Martin, N. J.; Rodin, I.; Smythe, P. J. // British Journal of Psychiatry;May97, Vol. 170, p431 

    Background: The suppression of melatonin by light at 00.30 hours has been shown to be greater in winter than in summer on patients with seasonal affective disorder (SAD) but not in matched normal controls.Method: In this study 12 patients with SAD and 12 matched normal...

  • Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study. Strang, John; Reed, Kylie; Bogdanowicz, Karolina; Bell, James; van der Waal, Rob; Keen, Jenny; Beavan, Pete; Baillie, Shelagh; Knight, alastair // European Addiction Research;May2017, Vol. 23 Issue 2, p61 

    Aims: To test the safety of new buprenorphine oral lyophilisate wafer ("bup-lyo") versus standard sub-lingual buprenorphine ("bup-SL").Design: Randomised (2:1) open-label study; opioid-dependent subjects; subsequent partial cross-over.Settings: Specialised...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics